This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Clinical Trials in the EU/EEA: focus on CMC aspects
Published on: Sept 30, 2013
Clinical Trials in the EU/EEA- Focus on CMC Aspects
Clinical trials testing the Benefit/Risk ratio of Investigational Medicinal Products (IMPs) in the European Union/European Economic Area (EU/EEA) are governed currently by Directive 2001/20/EC. This has led to different requirements amongst the Competent Authorities (CAs) and Ethics Committees (ECs) of each concerned MS.
Jilla Boulas, Delphine Decker, Valerie Pimpaneau, Florence Philippoz
2013 – Pharmaceutical Outsourcing